Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia Areata is an autoimmune condition often starting before age 20, with varied treatment success and a need for personalized treatment plans.

PCOS starts in adolescence with hormonal issues, leading to adult health problems, and early treatment is crucial.

Some drugs can cause hair loss, change hair color and shape, or increase hair growth, and treatment may involve stopping the drug or using specific hair growth treatments.

The document concludes that hirsutism is the main sign for diagnosing hyperandrogenism, which requires a detailed patient history and physical exam.

Hair mineral analysis might help diagnose diseases early, but standard methods are needed.

The document concludes that understanding sulfation biology is crucial for creating treatments due to its importance in biological functions and disease.

Low iron levels are not directly linked to chronic hair loss and iron supplements may not help.

The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.

Choosing the right recall period for patient feedback is important for accurate data and depends on the disease, symptom changes, and patient impact.

Methotrexate reduced the need for steroids in asthma patients without worsening their condition.

Correcting nutrient deficiencies may help with hair loss, but the benefits of supplements without a deficiency are uncertain and could be harmful.

A new gene, JMJD1C, may affect testosterone levels in men.

New treatments for male hypogonadism are effective and should be personalized.

Aromatase gene variation may increase female hair loss risk.

Testosterone with or without finasteride doesn't improve thinking skills in older men with low testosterone.

The document concludes that accurate measurement of serum androgens is crucial for diagnosing hyperandrogenism.

The document concludes that proper diagnosis and FDA-approved treatments for different types of hair loss exist, but treatments for severe cases often fail and future improvements may focus on hair follicle stem cells.

Women with PCOS often have skin problems like excessive hair, acne, hair loss, and dark patches, which can be treated with hormonal and non-hormonal therapies.

Androgens play a role in female sexual function, and testosterone therapy can help women with low sexual desire, but more research is needed on treatments and long-term safety.

Zinc deficiency in children can cause skin issues and can be serious if not diagnosed and treated properly.

Minoxidil and finasteride are effective for male hair loss, minoxidil for female hair loss, and various treatments like corticosteroids work for alopecia areata; treatment should be tailored to the individual.

Mushrooms have beneficial properties for skin and hair care products and have great potential for future cosmetic use.

Polycystic ovarian shape is a genetic sign of PCOS and its hormonal and metabolic features can be inherited.

Some women with common hair loss may develop permanent hair loss.

S5αR inhibitors might help treat schizophrenia and other mental disorders but need more research.

CCCA is a scarring hair loss condition mainly in African descent women, possibly caused by genetics and hairstyling, treated with gentle hair care and medications.

Long-term testosterone therapy can cause hormone suppression, affect prostate and heart health, and alter physical characteristics, but does not increase prostate cancer risk and needs more research for full risk assessment.

Women with PCOS have higher androgen levels that decrease with age but are still higher than in women without PCOS.

PCOS in teens is hard to diagnose, linked to genetics and lifestyle, and managed with weight loss and medication.

Women with PCOS who have low SHBG are more likely to have low good cholesterol and metabolic syndrome.